Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05825001 · ClinicalTrials.gov registry record · NA
Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers
A NA study of Cigarette Smoking-Related Carcinoma, sponsored by Roswell Park Cancer Institute.
- Active
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT05825001 is a NA study of Cigarette Smoking-Related Carcinoma that is active but no longer recruiting, run by Roswell Park Cancer Institute. The registered enrollment target is 104 participants, below the 462-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05825001, a NA study of Cigarette Smoking-Related Carcinoma, is active but no longer recruiting, sponsored by Roswell Park Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial evaluates the effectiveness of active episodic future thinking (EFT) stimuli for reducing cigarette consumption in cigarette smokers. EFT is an innovative framing method shown to significantly activate brain regions involved in future thinking, planning, and other executive functions. Active EFT stimuli are positive events, unrelated to smoking, that participants anticipate, look forward to, and can vividly imagine happening up to 1 year in the future. Control EFT stimuli are positive past events, unrelated to smoking, that participants can vividly remember happening in the recent past. Active EFT stimuli may help reduce cigarette consumption among cigarette smokers by exposing them to personally relevant future oriented stimuli.
Conditions Studied
Interventions
- BEHAVIORAL Smoking Cessation Intervention
- OTHER Medical Device Usage and Evaluation
- BEHAVIORAL Smoking Cessation Intervention (control)
Study Locations (1)
New York
- Roswell Park Comprehensive Cancer Center - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2024-09-15 |
| Est. Completion | 2026-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05825001
The ClinicalTrials.gov registry entry for NCT05825001 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 462-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (77% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cigarette Smoking-Related Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Smoking Cessation Intervention is the first listed.
NCT05825001 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05825001 about?
NCT05825001 is a clinical study titled "Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers". This clinical trial evaluates the effectiveness of active episodic future thinking (EFT) stimuli for reducing cigarette consumption in cigarette smokers. EFT is an innovative framing method shown to significantly activate brain regions involved in future thinking, planning, and other executive funct...
What is the current status of trial NCT05825001?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2024-09-15. Estimated completion is 2026-10-01.
What conditions does trial NCT05825001 study?
This clinical trial studies the following conditions: Cigarette Smoking-Related Carcinoma.
What interventions are being tested in trial NCT05825001?
The interventions under investigation include: Smoking Cessation Intervention (BEHAVIORAL), Medical Device Usage and Evaluation (OTHER), Smoking Cessation Intervention (control) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05825001?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05825001 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking-Related Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial
RECRUITING · NA
-
CONNECTing to LungCare
RECRUITING · NA
-
Smoking Cessation Intervention Development for Homeless Youth
RECRUITING · NA
-
Studying Flavors and Cooling Agents in Oral Nicotine Pouches to Understand User Preferences
RECRUITING · NA
-
Oral Nicotine Pouches Versus Nicotine Replacement Therapy to Reduce Cigarette Use for Smokers in Rural Appalachia
RECRUITING · NA
-
A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.